Printing

The future of medicine is here.

CELLINK’s patent-pending bioink is a biomaterial innovation that enables cells to grow and thrive as they would in their natural environment.

The world’s first universal bioink

CELLINK developed the first universal bioink that’s compatible with any cell type in any 3D-bioprinting system. CELLINK® Bioink combines the advantages of shear-thinning nanofibrillar cellulose and the versatility of alginate. Both components are naturally derived under strict quality control and assurance procedures – ensuring consistency within and across your research experiments.

Together, we print history!

CELLINK distributes products to more than 600 prestigious labs in more than 50 countries.

50
Countries
110
Employees
600
Labs

From nothing to a super-IPO

Cellink is making it possible to 3D-print human tissues and organs.

New ear, nose, or patella?

This new 3D printer can create bones and soft tissue.

Successful implant

The researchers created a gel composed of human cartilage cells, printed it through a CELLINK 3D bioprinter and implanted the material.

Solving organ transplant shortage

The impact of Cellink, especially considering its tender years, has been remarkable.

Cellink - a gem

In just a short time span, CELLINK has won several awards.

Bioprinting - The new industry

The company has gone on to develop tissue-specific bio-inks that contain growth factors needed to stimulate particular types of cells.

Life at CELLINK

We design and commercialize bioprinting technologies – enabling researchers to 3D print organs and tissue for applications that span industries, from pharmaceutical to cosmetic.

Follow on Instagram